Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Ucrio Yhenovo
Jun 18, 2021 8:57AM ET
to the moon
2
5
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
CureVac NV (CVAC)
NASDAQ
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| CVAC | NASDAQ | USD | Real-time | |
| 5CV | Xetra | EUR | Delayed | |
| 5CV | Frankfurt | EUR | Delayed | |
| 5CV | TradeGate | EUR | Delayed |
Add to/Remove from a Portfolio
Add to Portfolio
61.94
+4.11
+7.11%
Pre Market
64.98
+3.04
+4.91%
5:43:48 - Real-time Data
- Volume: 6,807,987
- Bid/Ask: 64.68 / 64.99
- Day's Range: 60.61 - 68.36
CureVac NV
61.94
+4.11
+7.11%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Insights
- Overview
- Profile
- Historical Data
- Index Component
CureVac NV is a component of the following Indices
See which major and sector indices this stock is a component of.
| Index | Last | High | Low | Chg. | Chg. % | Time | ||
|---|---|---|---|---|---|---|---|---|
| Nasdaq | 14,030.38 | 14,129.22 | 14,009.04 | -130.97 | -0.92% | 18/06 |
Write your thoughts about CureVac NV
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Rafael Müller
Jun 18, 2021 6:38AM ET
it is as simple as that: Buy on bad news. Best from Berlin
4
3
Ruroni Kenshin
Jun 18, 2021 6:16AM ET
Yesterday it open at 47, a magical opportunity and now the premarket is 67 and people don't want this stock. are you crazy !!! People talk about bankrut for curevac. You so funny!!!!
4
0
Ucrio Yhenovo
Jun 17, 2021 5:13PM ET
tomorrow?
0
0
Elon Musk
Jun 17, 2021 4:11PM ET
the same story like Wirecard will bankrupt soon . Sell and take your damage back for ever. Curevac again one more scandal like Wirecard.! German stories.!-(((
1
6
Gio Di Pietro
Jun 17, 2021 12:42PM ET
Haha and the german says, Ex president Trump wanted to buy this ******** :D German liar to advertise yourself
2
2
Patryk Sl
Jun 17, 2021 5:37AM ET
lol, market cap 18bln$ with 17mln$ in revenue....
7
0
Оля Раваева
Jun 17, 2021 5:37AM ET
Exactly, I just wonder why it isn't zero yet
2
0
Carlos GV
Jun 17, 2021 4:56AM ET
target for CVAC! After this drop I am thinking of gettin in...
5
2
Nash Purswani
Jun 17, 2021 4:56AM ET
Any chance it cud go bust like Wirecard
0
2
Calvin Loo
Jun 17, 2021 4:56AM ET
wow, you are brave
0
0
Piljin k
Jun 17, 2021 4:34AM ET
Guys , relax and look at this objectivelyit is very hard forecast. anyway i am ok about this situation, because i did not buy this stock
2
2
Angelvs MG
Jun 17, 2021 4:34AM ET
Man you´re my hero xD
0
0
Raj Aggarwal
Jun 17, 2021 4:34AM ET
I sold it a while back
0
0
Piljin k
Jun 17, 2021 4:34AM ET
Guys , relax and look at this objectivelyit is very hard forecast. anyway i am ok about this situation, because i did not buy this stock
0
0
WBFT
Jun 17, 2021 3:16AM ET
Washington Post: CureVac, the latest experimental coronavirus vaccine, proved just 47 percent effective amid spread of variants, preliminary analysis shows
1
0
Elon Musk
Jun 17, 2021 2:25AM ET
CureVac will bankrupt soon . forget it sell and run out . On September this CureVac will never exist . big institutions today already sold out in TradeGate .
3
6
Cechieri
Jun 17, 2021 2:25AM ET
"Both the World Health Organization and the Food and Drug Administration set a threshold of 50 percent efficacy to consider Covid-19 vaccines for emergency authorization. If CureVac were to stay at 47 percent in the final analysis, it would fail to meet that standard". - testing is not finished yet, so if they reach 50% it should do the deal
3
0
Saad Rizwan
Jun 17, 2021 2:25AM ET
C e c h i e r i but why would anyone buy it when there is more effective vaccines and the countries lagging would buy cheaper vaccines
2
0
Cechieri
Jun 17, 2021 2:25AM ET
Because there is not enough of other vaccs, I think - till a cheaper and even worse vac can be applied in emergency if only approved, they are ordered already "The news was disappointing to experts who had hoped the company could provide vaccines for low- and middle-income countries that don’t have nearly enough. CureVac had some advantages over the other mRNA vaccines, such as keeping stable for months in a refrigerator. What’s more, compared with its competitors, CureVac’s vaccine used fewer mRNA molecules per jab, lowering its cost."
2
1
Cechieri
Jun 17, 2021 2:25AM ET
still*
0
1
Elon Musk
Jun 17, 2021 2:25AM ET
expiry date September 2021 . after you will loose your money sell out to save your capital.
0
0
Lester Regina
Jun 16, 2021 7:08PM ET
I will add more..nothing changes in the long term outlook
5
5
felix mueller
Jun 16, 2021 7:08PM ET
Serious question: why does nothing change? If they cannot get approval because it is not efficiant, they wont be able to sell their millions and millions of doses which they have already orders for. This cant be good LT. Management did not always take the right decisions in the last year which is not positive either…? How effective is their mrna staff and lab researchers? Hmmm. Having serious doubts here.
4
3
Cechieri
Jun 16, 2021 7:08PM ET
they need 50% to approve - it is 47% now and the trial still in progress. It's for countries which don't have enough vaccines anyway
1
0
Cechieri
Jun 16, 2021 6:02PM ET
Bad news - CureVac (CVAC/5CV GY) says its COVID-19 vaccine demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity and did not achieve prespecified statistical success criteria
2
0
WBFT
Jun 16, 2021 9:07AM ET
buying time for new entrants..
1
3
mudlog79
Jun 16, 2021 9:07AM ET
oh really?
0
0
Rafael Müller
Jun 14, 2021 6:19AM ET
From the Motley Fool Germany. Just use Google Translate.
https://www.onvista.de/news/curevac-aktie-trader-druecken-den-kurs-fuer-eine-interesssante-langfristige-einstiegschance-464032327
0
1
WBFT
Jun 11, 2021 7:44AM ET
soon 90..
3
2
Elliot Alderson
Jun 11, 2021 7:44AM ET
not today
0
0
Khalil Khalilov
Jun 11, 2021 4:17AM ET
What happens in pre?
1
0
Eszter Kálózdi
Jun 08, 2021 11:20AM ET
https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.html
2
0
Calvin Loo
Jun 08, 2021 11:20AM ET
thanks
0
0
Calvin Loo
Jun 08, 2021 9:57AM ET
huge drop today, any news that cause this ?
0
0
Rafael Müller
Jun 08, 2021 9:57AM ET
approval is 2 month postponed
0
0
atıl eren
Jun 08, 2021 8:15AM ET
what happened?
0
0
André Lucas
Jun 08, 2021 8:15AM ET
https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.htmlThe European Medicines Agency (EMA) does not expect to make a decision on the approval of German biotech group CureVac's COVID-19 vaccine before August, an off...
1
0
Elliot Alderson
Jun 07, 2021 10:22AM ET
Approval...this week???
2
2
Ajeng Pratitie
Jun 07, 2021 10:22AM ET
I hope so.... 🤞
0
0
Rafael Müller
May 28, 2021 4:30AM ET
Greatings from Germany. I guess it is a matter of days until we see the next move. As soon as we get some news in, the stock will follow the valuations of Moderna and Biontech (in your country you say Pfizer for the vaccine, but in realty it is Biontech.Alsdo German. The valuation of Biontech is 2,3 times higher and Curevac has the same product as well a a very famous shareholder
. At the End of the year we will see the same valutaion for both. My guess is arround 80-100 billion. Best
7
1
Elliot Alderson
May 28, 2021 4:30AM ET
Thanks...I really hope you are right!
1
0
Hasan Kosebalaban
May 28, 2021 4:30AM ET
But the vaccine market is saturated now with the West nearly half vaccinated already.
1
0
Hasan Kosebalaban
May 28, 2021 4:30AM ET
Hope so. It is a solid company with a solid product (mRNA). Essentially same stuff as Biontech and Moderna. nice to meet you, dear neighbour.
0
0
Nick Neri
May 25, 2021 12:54AM ET
New Highs on way
2
0
Ruroni Kenshin
May 25, 2021 12:54AM ET
after this resistance the way look's clean
0
0
Cechieri
May 06, 2021 4:14PM ET
"Changes to international intellectual property rules require unanimous agreement" (...) ""The activists said a waiver alone would not increase the world’s vaccine supply. It must be accompanied by a process known as “tech transfer,” in which patent holders supply technical know-how and personnel." (...) “Handing needy countries a recipe book without the ingredients, safeguards and sizable work force needed will not help people waiting for the vaccine,” Dr. Michelle McMurry-Heath." (NYTIMES)
I don't see that happening TBH. Just hard to imagine the cake will be shared or maybe I'm too cynical for this level of humanitarianism. Looking for a dip. What do you think?
6
1
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.